NMTR 9 Meters Biopharma Inc

Price (delayed)

$1.34

Market cap

$336.84M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.59

Enterprise value

$298.5M

Highlights
9 Meters Biopharma's debt has shrunk by 96% YoY and by 15% QoQ
NMTR's EPS is up by 19% YoY
NMTR's net income has dropped by 142% year-on-year and by 3% since the previous quarter

Key stats

What are the main financial stats of NMTR
Market
Shares outstanding
251.37M
Market cap
$336.84M
Enterprise value
$298.5M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
8.5
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$59.81M
EBITDA
-$59.79M
Free cash flow
-$23.01M
Per share
EPS
-$0.59
Free cash flow per share
-$0.11
Book value per share
$0.16
Revenue per share
$0
TBVPS
$0.19
Balance sheet
Total assets
$40.21M
Total liabilities
$6.14M
Debt
$154,846
Equity
$34.07M
Working capital
$34M
Liquidity
Debt to equity
0
Current ratio
6.68
Quick ratio
6.44
Net debt/EBITDA
0.64
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-234.6%
Return on equity
-347.5%
Return on invested capital
N/A
Return on capital employed
-174.8%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NMTR stock price

How has the 9 Meters Biopharma stock price performed over time
Intraday
-6.29%
1 week
-8.22%
1 month
12.61%
1 year
127.12%
YTD
55.81%
QTD
14.53%

Financial performance

How have 9 Meters Biopharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$54.85M
Net income
-$63.32M
Gross margin
N/A
Net margin
N/A
NMTR's net income has dropped by 142% year-on-year and by 3% since the previous quarter
The operating income has plunged by 126% YoY and by 2.1% from the previous quarter

Growth

What is 9 Meters Biopharma's growth rate over time

Valuation

What is 9 Meters Biopharma stock price valuation
P/E
N/A
P/B
8.5
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
NMTR's EPS is up by 19% YoY
The P/B is 44% below the last 4 quarters average of 15.2
The equity has increased by 6% QoQ

Efficiency

How efficient is 9 Meters Biopharma business performance
9 Meters Biopharma's return on equity has surged by 63% QoQ
The ROA has grown by 32% from the previous quarter and by 26% YoY

Dividends

What is NMTR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NMTR.

Financial health

How did 9 Meters Biopharma financials performed over time
NMTR's total liabilities has dropped by 61% year-on-year and by 12% since the previous quarter
The current ratio rose by 18% since the previous quarter
9 Meters Biopharma's debt is 100% lower than its equity
9 Meters Biopharma's debt to equity has shrunk by 100% QoQ but it has surged by 100% YoY
9 Meters Biopharma's debt has shrunk by 96% YoY and by 15% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.